Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Safe cosmetics without animal testing? Contributions of the EU Project Sens-it-iv

In English

Författare

  • Hans Ulrich Weltzien
  • Emanuela Corsini
  • Sue Gibbs
  • Malin Lindstedt
  • Carl Borrebaeck
  • Petra Budde
  • Peter Schulz-Knappe
  • Hermann-Josef Thierse
  • Stefan F. Martin
  • Erwin L. Roggen

Summary, in English

The 7th Ammendment to the Cosmetics Directive of the European Commission (Directive 76/768/EEC2) bans the marketing of cosmetics containing animal-tested ingredients since March 2009. Excepted are only tests for repeated dose toxicity, for which the animal ban will come into effect by 2013. One major concern for cosmetics, i.e. the risk of containing skin (contact) sensitizers, has in the past been addressed almost exclusively by animal testing. It is this problem attracting the central interest of the integrated research project Sens-it-iv (Novel Testing Strategies for in vitro Assessment of Allergens, http://www.sens-it-iv.eu ), funded by the EC within framework 6 since October 2005. Here, the 28 Sens-it-iv partners from 10 European States present the 5 most promising types of in vitro assays selected for further refinement. These are: (1) a human epidermal equivalent (EE) model to rank contact allergens according to their sensitizing potency, (2) identification of contact sensitizers, including pro-haptens, through intracellular production of IL-18 by the human keratinocyte cell line NCTC 2544, (3) determination of activation markers such as CD86, CD54 and most prominently CXCL8 (IL-8) on/in dendritic cell lines, (4) contact sensitizer-specific migration of MUTZ Langerhans cells towards the chemokine CXCL12, and (5) the allergen-specific activation and proliferation of na < ve human T cells. Ongoing genomic and proteomic experiments are in the process of identifying larger sensitizer-specific biological marker signatures to be integrated into the above assays. We hope to supply the European control agencies with a basis for further validation of in vitro assays by the end of 2010.

Publiceringsår

2009

Språk

Engelska

Sidor

41-48

Publikation/Tidskrift/Serie

Journal für Verbraucherschütz und Lebensmittelsicherheit

Volym

4

Issue

suppl. 2

Dokumenttyp

Artikel i tidskrift

Förlag

Birkhäuser Verlag

Ämne

  • Immunology in the medical area

Nyckelord

  • Allergy
  • Contact
  • Sensitizer
  • In vitro
  • Alternative
  • Animal
  • Cosmetic

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1661-5867